|
End-of-day quote
Shenzhen S.E.
2026-10-21
|
5-day change | 1st Jan Change | ||
| 3.240 CNY | +2.21% |
|
-1.82% | +5.54% |
| Market Cap | 7.22B 1.08B 964M 893M 808M 1.52B 102B 1.54B 10.7B 4.2B 53.67B 4.06B 3.97B 171B | P/E 2024 |
24.2x | P/E 2025 | 18.2x |
|---|---|---|---|---|---|
| Enterprise Value | 6.39B 957M 852M 789M 714M 1.35B 90.26B 1.36B 9.46B 3.71B 47.45B 3.59B 3.51B 151B | EV / Sales 2024 |
2.12x | EV / Sales 2025 | 2.82x |
| Free-Float |
90.2% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +2.21% | ||
| 1 week | -1.82% | ||
| Current month | -11.23% | ||
| 1 month | -13.37% | ||
| 3 months | +14.49% | ||
| 6 months | -13.14% | ||
| Current year | +5.54% |
| 1 week | 3.1 |  | 3.61 |
| 1 month | 3.1 | | 3.78 |
| Current year | 2.37 | | 5.1 |
| 1 year | 2.37 | | 5.1 |
| 3 years | 1.66 | | 5.1 |
| 5 years | 1.66 | | 5.1 |
| 10 years | 1.66 | | 9.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lei Feng Guo
CEO | Chief Executive Officer | 53 | 2022-12-25 |
Kang Zhou
PRN | Corporate Officer/Principal | 42 | 2018-04-17 |
Yue Yin Liu
PRN | Corporate Officer/Principal | 40 | 2019-05-22 |
| Director | Title | Age | Since |
|---|---|---|---|
Yue Yin Liu
BRD | Director/Board Member | 40 | 2025-03-13 |
Lei Feng Guo
BRD | Director/Board Member | 53 | 2022-11-10 |
Kang Zhou
BRD | Director/Board Member | 42 | 2022-11-10 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/2/25 | Sell | 587,500 | 0.0283% | |||
| 7/2/25 | Sell | Director | 259,600 | 0.0125% | ||
| 7/2/25 | Sell | 587,500 | 0.0283% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.21% | -1.82% | -0.31% | +52.11% | 1.06B | |
| -1.01% | +5.13% | +58.93% | +117.36% | 1,144B | |
| -0.61% | +1.52% | +34.34% | +68.48% | 625B | |
| -1.48% | +0.47% | +23.08% | +94.76% | 511B | |
| +0.54% | +5.69% | +39.60% | +64.02% | 377B | |
| +1.07% | +1.70% | +71.06% | +45.98% | 366B | |
| +0.30% | +3.44% | +21.35% | +49.62% | 291B | |
| -0.03% | +2.55% | +1.12% | +20.94% | 262B | |
| -0.14% | +2.87% | +45.56% | +57.22% | 237B | |
| -1.88% | +0.02% | +23.77% | +97.39% | 194B | |
| Average | +0.19% | +3.30% | +31.85% | +66.79% | 400.9B | |
| Weighted average by Cap. | +0.33% | +4.17% | +40.80% | +79.56% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.44B 366M 326M 302M 273M 514M 34.5B 520M 3.62B 1.42B 18.13B 1.37B 1.34B 57.78B | 2.14B 320M 285M 264M 239M 450M 30.18B 455M 3.16B 1.24B 15.86B 1.2B 1.17B 50.55B |
| Net income | 233M 34.86M 31.06M 28.76M 26.03M 49.03M 3.29B 49.62M 345M 135M 1.73B 131M 128M 5.51B | 377M 56.45M 50.3M 46.57M 42.14M 79.4M 5.33B 80.34M 558M 219M 2.8B 212M 207M 8.92B |
| Net Debt | -509M -76.18M -67.89M -62.85M -56.88M -107M -7.19B -108M -754M -296M -3.78B -286M -280M -12.04B | -838M -126M -112M -104M -93.71M -177M -11.84B -179M -1.24B -487M -6.23B -471M -461M -19.84B |
Employees
2,350
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-21 | CN¥3.240 | +2.21% | 321,691,407 |
| 26-10-20 | CN¥3.170 | -2.76% | 244,144,193 |
| 26-10-19 | CN¥3.260 | -7.65% | 424,017,617 |
| 26-10-16 | CN¥3.530 | +7.62% | 601,413,108 |
| 26-10-15 | CN¥3.280 | -0.61% | 263,617,741 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 002437 Stock
Select your edition
All financial news and data tailored to specific country editions
